DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Lunelle (Medroxyprogesterone Acetate / Estradiol Cypionate) - Summary

 

-- advertisement --

LUNELLE SUMMARY

LUNELLE™ Monthly Contraceptive Injection contains medroxyprogesterone acetate and estradiol cypionate as its active ingredients.

LUNELLE™ Monthly Contraceptive Injection is indicated for the prevention of pregnancy.

The efficacy of LUNELLE™ Monthly Contraceptive Injection is dependent on adherence to the recommended dosage schedule (e.g., intramuscular injections every 28 to 30 days, not to exceed 33 days). To ensure that LUNELLE™ Monthly Contraceptive Injection is not administered inadvertently to a pregnant woman, the first injection should be given during the first 5 days of a normal menstrual period. LUNELLE™ Monthly Contraceptive Injection should be administered no earlier than 4 weeks after delivery if not breastfeeding or 6 weeks after delivery if breastfeeding (see NURSING MOTHERS).

LUNELLE NEWS HIGHLIGHTS

Media Articles Related to Lunelle (Medroxyprogesterone / Estradiol)

Leavitt's Actions On HHS Draft Rule Leave Possibility That It Will Be Used To Refuse Contraception, Opinion Piece Says
Source: Sexual Health / STDs News From Medical News Today [2008.09.03]

Governor Palin Is Pro-Life, Pro-contraception, And Pro-competition In Health Care
Source: Abortion News From Medical News Today [2008.08.30]

New Concepts In Contraception
Source: Sexual Health / STDs News From Medical News Today [2008.08.28]

'Extended Cycle' Contraception Garners More Interest
Source: MedicineNet Birth Control Specialty [2008.08.25]

Male Contraception: Progress Slow but Steady
Source: MedicineNet Vasectomy Specialty [2008.04.14]

more>>

Published Studies Related to Lunelle (Medroxyprogesterone / Estradiol)

Effects in postmenopausal women of estradiol and medroxyprogesterone alone and combined on resistance artery function and endothelial morphology and movement. [2008.05]

Estrogen, medroxyprogesterone acetate, endothelial function, and biomarkers of cardiovascular risk in young women. [2008.04]

A comparative study of Cyclofem and depot medroxyprogesterone acetate (DMPA) effects on endometrial vasculature. [2007.10]

Oral medroxyprogesterone acetate and combination oral contraceptives for acute uterine bleeding: a randomized controlled trial. [2006.10]

Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception. [2005.01]

more>>

Page last updated: 2008-09-03

-- advertisement -- The American Red Cross

We comply with
HONcode standard.
Verify here.
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2008